Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity

Literals

• vivo:identifier
  • 2008-2390
• dcterms:contributor
  • Llerena A, Dorado P, Peñas-Lledó EM
• ou:urlOrcid
  • http://europepmc.org/abstract/med/19102711
• bibo:eissn
  • 1744-8042
• ou:eid
  • 2-s2.0-62649122990
• dcterms:creator
  • Llerena A.
• bibo:doi
  • 10.2217/14622416.10.1.17
• fabio:hasPublicationYear
  • 2008
• bibo:issn
  • 1462-2416
• bibo:page_range
  • 17-28
• dcterms:publisher
  • Pharmacogenomics
• ou:tipoPublicacion
  • Journal
• dcterms:title
  • Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity
• vcard:url
  • https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=62649122990&origin=inward
• ou:urlScopus
  • https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=62649122990&origin=inward
• bibo:volume
  • 10

Typed Literals

• ou:vecesCitado
  • 65 (xsd:integer)

Inverse Relations

• Has related: ou:tienePublicacion
  • ADRIÁN LLERENA RUIZ
  • EVA MARÍA PEÑAS LLEDÓ
  • PEDRO DORADO HERNÁNDEZ